Patriot Financial Group Insurance Agency’s Alaunos Therapeutics TCRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-1
Closed 1995
2020
Q3
$0 Hold
1
﹤0.01% 1842
2020
Q2
$0 Hold
1
﹤0.01% 1834
2020
Q1
$0 Hold
1
﹤0.01% 1731
2019
Q4
$0 Hold
1
﹤0.01% 1443
2019
Q3
$0 Hold
1
﹤0.01% 1457
2019
Q2
$1K Hold
1
﹤0.01% 1336
2019
Q1
$0 Hold
1
﹤0.01% 1307
2018
Q4
$0 Hold
1
﹤0.01% 1108
2018
Q3
$1K Hold
1
﹤0.01% 947
2018
Q2
$0 Buy
+1
New +$634 ﹤0.01% 893
2017
Q4
Sell
-1
Closed -$1K 965
2017
Q3
$1K Buy
+1
New +$888 ﹤0.01% 897

Other funds holding TCRT

Patriot Financial Group Insurance Agency's TCRT Position: Q4 2020 in Review

Patriot Financial Group Insurance Agency sold out of Alaunos Therapeutics (TCRT) in Q4 2020, closing a stake of 1 share.

Patriot Financial Group Insurance Agency first reported a position in TCRT in Q3 2017 and held it in 11 quarters. The position peaked at $1K in Q2 2019. 156 funds tracked by Wall St. Rank hold TCRT as of Q4 2020.

  • Patriot Financial Group Insurance Agency reported no remaining Alaunos Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Patriot Financial Group Insurance Agency sold 1 Alaunos Therapeutics share in Q4 2020.
  • Patriot Financial Group Insurance Agency first reported a position in Alaunos Therapeutics in Q3 2017 and held it in 11 quarters.
  • Patriot Financial Group Insurance Agency's Alaunos Therapeutics position peaked at $1K in Q2 2019.
  • 156 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q4 2020.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q4 2020, filed 15 Jan 2021.